KR100610517B1 - 건선 치료용 매니큐어액 - Google Patents

건선 치료용 매니큐어액 Download PDF

Info

Publication number
KR100610517B1
KR100610517B1 KR1019980033706A KR19980033706A KR100610517B1 KR 100610517 B1 KR100610517 B1 KR 100610517B1 KR 1019980033706 A KR1019980033706 A KR 1019980033706A KR 19980033706 A KR19980033706 A KR 19980033706A KR 100610517 B1 KR100610517 B1 KR 100610517B1
Authority
KR
South Korea
Prior art keywords
copolymers
acid
vinyl
nail polish
vinyl acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019980033706A
Other languages
English (en)
Korean (ko)
Other versions
KR19990023719A (ko
Inventor
만프레트 본
칼 테오도르 크레머
Original Assignee
사노피-아벤티스 도이칠란트 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사노피-아벤티스 도이칠란트 게엠베하 filed Critical 사노피-아벤티스 도이칠란트 게엠베하
Publication of KR19990023719A publication Critical patent/KR19990023719A/ko
Application granted granted Critical
Publication of KR100610517B1 publication Critical patent/KR100610517B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Finger-Pressure Massage (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019980033706A 1997-08-21 1998-08-20 건선 치료용 매니큐어액 Expired - Fee Related KR100610517B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19736112 1997-08-21
DE19736112.9 1997-08-21

Publications (2)

Publication Number Publication Date
KR19990023719A KR19990023719A (ko) 1999-03-25
KR100610517B1 true KR100610517B1 (ko) 2007-04-25

Family

ID=7839551

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980033706A Expired - Fee Related KR100610517B1 (ko) 1997-08-21 1998-08-20 건선 치료용 매니큐어액

Country Status (35)

Country Link
US (3) US6352686B2 (enExample)
EP (1) EP0913154B1 (enExample)
JP (1) JPH11130679A (enExample)
KR (1) KR100610517B1 (enExample)
CN (1) CN1155386C (enExample)
AR (1) AR015933A1 (enExample)
AT (1) ATE227993T1 (enExample)
AU (1) AU740615B2 (enExample)
BG (1) BG63270B1 (enExample)
BR (1) BR9803756A (enExample)
CA (1) CA2245637C (enExample)
CO (1) CO4960649A1 (enExample)
CZ (1) CZ292344B6 (enExample)
DE (1) DE59806343D1 (enExample)
DK (1) DK0913154T3 (enExample)
ES (1) ES2186952T3 (enExample)
HR (1) HRP980458B1 (enExample)
HU (1) HUP9801898A3 (enExample)
ID (1) ID20731A (enExample)
IL (1) IL125854A (enExample)
MY (1) MY128558A (enExample)
NO (1) NO319391B1 (enExample)
NZ (1) NZ331443A (enExample)
PL (1) PL192342B1 (enExample)
PT (1) PT913154E (enExample)
RO (1) RO118174B1 (enExample)
RU (1) RU2210354C2 (enExample)
SG (1) SG68072A1 (enExample)
SI (1) SI0913154T1 (enExample)
SK (1) SK284218B6 (enExample)
TR (1) TR199801609A3 (enExample)
TW (1) TW590776B (enExample)
UA (1) UA51693C2 (enExample)
YU (1) YU49492B (enExample)
ZA (1) ZA987531B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
NZ526806A (en) * 2001-01-09 2006-03-31 Israel Dvoretzky Therapeutic film forming composition and treatment system
FR2830449B1 (fr) * 2001-10-05 2004-04-23 Fabre Pierre Dermo Cosmetique Utilisation du tazarotene pour la preparation d'un vernis a ongles pour le traitement et/ou la prevention du psoriasis et un vernis a ongles le contenant
FR2835180B1 (fr) * 2002-01-30 2004-04-09 Fiabila Vernis a ongles multiphase
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
BR0315195A (pt) * 2002-12-17 2005-08-23 Galderma Sa Composições farmacêuticas e usos das composições
FR2848454B1 (fr) * 2002-12-17 2007-03-30 Galderma Res & Dev Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
EP1875916A3 (en) * 2002-12-17 2008-01-23 Galderma S.A. Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate
US7238533B1 (en) * 2003-07-22 2007-07-03 Ronald Legge Personal illicit drug detection method
FR2871699A1 (fr) * 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
JP4608618B2 (ja) * 2004-07-02 2011-01-12 有限会社 エヌ・ピィ・アール ネイルアート用溶液
US20060062982A1 (en) * 2004-09-17 2006-03-23 Massachusetts Institute Of Technology Carbon-polymer electrochemical systems and methods of fabricating them using layer-by-layer technology
CA2498623A1 (en) * 2005-02-18 2006-08-18 Qlt Inc. Treatment of onychomycosis
WO2006111426A1 (en) * 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
FR2884419B1 (fr) * 2005-04-19 2007-06-22 Galderma Sa Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
US8277780B2 (en) * 2005-05-27 2012-10-02 Taro Pharmaceutical North America, Inc. Stable liquid desoximethasone compositions with reduced oxidized impurity
KR100803926B1 (ko) 2006-07-27 2008-02-15 주식회사 코리아나화장품 샌드프리 화장료 조성물
US20090317341A1 (en) * 2008-06-18 2009-12-24 Conopco, Inc., D/B/A Unilever Compositions for Lightening Skin Color
FR2937250B1 (fr) * 2008-10-21 2013-05-10 Fabre Pierre Dermo Cosmetique Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle
EP3403654B1 (en) 2009-10-01 2019-07-31 Adare Development I, L.P. Orally administered corticosteroid compositions
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
PL233616B1 (pl) 2017-08-10 2019-11-29 Podopharm Spolka Z Ograniczona Odpowiedzialnoscia Preparat do paznokci, dloni i stop oraz sposob wytwarzania tego preparatu
WO2024024520A1 (ja) * 2022-07-28 2024-02-01 花王株式会社 外用剤組成物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928261A (en) * 1973-05-17 1975-12-23 Minnesota Mining & Mfg Water removable film-forming compositions for topical application to skin
US3861932A (en) * 1973-12-13 1975-01-21 Revlon Stabilization of nitrocellulose
US3966924A (en) * 1974-11-13 1976-06-29 Allergan Pharmaceuticals Composition and method for treating psoriasis
US4179304A (en) * 1978-04-03 1979-12-18 Polychrome Corporation Finger nail lacquer
US4210633A (en) * 1978-10-20 1980-07-01 Eli Lilly And Company Flurandrenolide film formulation
US4250164A (en) * 1979-04-09 1981-02-10 Bernstein Joel E Method of treating psoriasis of the nails and composition
EP0247142B1 (en) * 1985-11-04 1993-01-07 Owen/Galderma Laboratories Inc. Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
DE3612305A1 (de) * 1986-04-11 1987-10-22 Roehm Pharma Gmbh Fluessige arzneiform zur therapie der psoriasis auf basis filmbildender polymere
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
US5093108A (en) * 1989-02-16 1992-03-03 Amalia, Inc. Quick-drying nail enamel compositions and method for coating a surface
CA2008775C (en) * 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
US5258186A (en) * 1989-03-10 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Drug release controlling coating material for long acting formulations
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
DE19518262A1 (de) * 1995-05-18 1996-11-21 Hoechst Ag Die Verwendung von Glyceryltriacetat zur Behandlung von Onychomykosen
JP2735392B2 (ja) * 1993-07-28 1998-04-02 ファイザー・インコーポレーテッド 乾癬の治療法
DK128494A (da) * 1994-11-08 1996-05-09 Edel K Seidenschnur Behandling af keratinøse og psoriatiske sygdomstilstande med neglelak indeholdende vitamin D metabolit, eller derivat, og/eller vitamin A derivat
DE19529085A1 (de) * 1995-08-08 1997-02-13 Christiane Dr Med Wurdel Nagellack zur Bekämpfung der Schuppenflechte im Nagelbereich
AU1876797A (en) * 1996-03-16 1997-10-10 Hoechst Aktiengesellschaft Topical formulations for the treatment of nail psoriasis
GB9609653D0 (en) 1996-05-09 1996-07-10 Applied Research Ars Holding N Method of assay
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia

Also Published As

Publication number Publication date
IL125854A (en) 2004-02-19
BG63270B1 (bg) 2001-08-31
HUP9801898A3 (en) 2000-01-28
SK284218B6 (en) 2004-11-03
UA51693C2 (uk) 2002-12-16
CA2245637A1 (en) 1999-02-21
NO983818D0 (no) 1998-08-20
CN1209318A (zh) 1999-03-03
US20010006625A1 (en) 2001-07-05
TR199801609A2 (xx) 1999-03-22
NO319391B1 (no) 2005-08-08
DK0913154T3 (da) 2003-03-03
YU49492B (sh) 2006-08-17
AU8085698A (en) 1999-03-04
HUP9801898A1 (hu) 1999-04-28
NO983818L (no) 1999-02-22
ZA987531B (en) 1999-02-22
HRP980458A2 (en) 1999-06-30
NZ331443A (en) 1999-01-28
EP0913154B1 (de) 2002-11-20
CA2245637C (en) 2008-07-15
RU2210354C2 (ru) 2003-08-20
US20040071645A1 (en) 2004-04-15
AR015933A1 (es) 2001-05-30
IL125854A0 (en) 1999-04-11
SI0913154T1 (en) 2003-04-30
EP0913154A1 (de) 1999-05-06
ATE227993T1 (de) 2002-12-15
JPH11130679A (ja) 1999-05-18
HK1018214A1 (en) 1999-12-17
YU34998A (sh) 2002-11-15
KR19990023719A (ko) 1999-03-25
US6352686B2 (en) 2002-03-05
HRP980458B1 (en) 2002-12-31
CZ263298A3 (cs) 1999-03-17
PL328122A1 (en) 1999-03-01
CO4960649A1 (es) 2000-09-25
DE59806343D1 (de) 2003-01-02
US20020071815A1 (en) 2002-06-13
MY128558A (en) 2007-02-28
PT913154E (pt) 2003-04-30
AU740615B2 (en) 2001-11-08
TW590776B (en) 2004-06-11
RO118174B1 (ro) 2003-03-28
CN1155386C (zh) 2004-06-30
TR199801609A3 (tr) 1999-03-22
BR9803756A (pt) 2000-03-28
ES2186952T3 (es) 2003-05-16
ID20731A (id) 1999-02-25
SG68072A1 (en) 1999-10-19
BG102696A (en) 1999-04-30
HU9801898D0 (en) 1998-10-28
CZ292344B6 (cs) 2003-09-17
SK114398A3 (en) 1999-03-12
PL192342B1 (pl) 2006-10-31

Similar Documents

Publication Publication Date Title
KR100610517B1 (ko) 건선 치료용 매니큐어액
CA2093895C (en) Nail lacquer for the treatment of onychomycosis
JP2635104B2 (ja) 抗真菌作用のあるネイルラツカー
JPH0564924B2 (enExample)
WO1994015591A1 (fr) Composition de traitement de l'onychomycose
US20050002878A1 (en) Use of tazarotene for preparing a nail varnish for treating and/or preventing psoriasis and nail varnish containing same
JP2000512265A (ja) 爪の乾癬の治療のための局所投与用製剤
JP3212637B2 (ja) 被膜型皮膚保護剤
EP1874320A1 (en) Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
DE102004049740B4 (de) Selbstklebende Zahnfolie und Verfahren zur Herstellung der Zahnfolie
MXPA98006773A (en) Enamel for nails with activity antipsorias
KR100220403B1 (ko) 각질 투과 증가제를 기제성분으로 함유하는 항진균성 손.발톱 와니스
HK1018214B (en) Antipsoriatic nail polish
JPH0543440A (ja) にきび治療薬の製造方法

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20090803

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20090803

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000